Biology of Prostate Cancer

  • H. Schulze
Conference paper


At present there is no effective therapy for increasing the survival rate in patients with metastatic prostatic cancer. New approaches to this major disease are therefore urgently needed. One approach is to study biology of prostatic carcinogenesis in order to develop a therapeutic modality to prevent the initial development of clinically manifest prostatic cancer. As a general rule for any disease, prevention constitutes the optimal modality if it is at all practically possible. However, the question arises whether prevention of prostatic carcinogenesis is a realistic possibility. Based upon epidemiological data this does in fact appear possible. This is due to the fact that incidence and mortality rates of prostatic cancer in Oriental men are far lower than those in corresponding Western populations. For example, there is a nearly tenfold difference in the mortality rates due to prostatic cancer among men in the United States (14.8 deaths per 100000 men of all ages; [22]) versus Japan (1.8 deaths per 100000 men of all ages; [23]) although the overall life expectancy of men in these two countries is identical (70 in the United States versus 72 in Japan; [26]). When Japanese men migrate to California or Hawaii, however, the mortality rate of prostatic cancer increases dramatically in the first and second generations and becomes more similar to the high rates of United States men than the low rates of native Japanese [12]. These data may demonstrate that prostate carcinogenesis can be directly affected by environmental factors.


Prostatic Cancer Atypical Hyperplasia Prostatic Carcinogenesis Invasive Prostatic Cancer Pathol Bacteriol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Akazaki K, Stemmermann GN (1973) Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. JNCI 50:1137–1144PubMedGoogle Scholar
  2. 2.
    Altenähr E, Kastendieck H, Siefert H (1979) Koinzidenz von Prostatacarcinom und Dysplasie bei totalen Prostatektomien und Autopsien. Verh Dtsch Ges Pathol 63:415Google Scholar
  3. 3.
    Ashley DJ (1965) On the incidence of carcinoma of the prostate. J Pathol Bacteriol 90:217–224PubMedCrossRefGoogle Scholar
  4. 4.
    Bosland MC (1988) The etiopathogenesis of prostatic cancer with special reference to environmental factors. Adv Cane Res 51:1–106CrossRefGoogle Scholar
  5. 5.
    Brawn PN (1982) Adenosis of the prostate: a dysplastic lesion that can be combined with prostatic adenocarcinoma. Cancer 49:826–833PubMedCrossRefGoogle Scholar
  6. 6.
    Breslow N, Chan C, Dhom G, Drury R, Franks LM, Geller B, Lee Y, Lundberg S, Sparke B, Stemby N, Tulinius H (1977) Latent carcinoma of the prostate at autopsy in seven areas. Int J Cane 10:680–688CrossRefGoogle Scholar
  7. 7.
    Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathological features in 208 radical prostatectomies, examined by the step section technique. Cancer 30:5–13PubMedCrossRefGoogle Scholar
  8. 8.
    Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC (1981) Pathological factors that influence prognosis in a stage A prostatic cancer: the influence of extent versus grade. J Urol 125:516–520PubMedGoogle Scholar
  9. 9.
    Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni JF Jr (1987) Cancer incidence and mortality trends among whites in the United States, 1947–84. JNCI 79:701–770PubMedGoogle Scholar
  10. 10.
    Flanders, WD (1984) Review: prostate cancer epidemiology. Prostate 5:621–629PubMedCrossRefGoogle Scholar
  11. 11.
    Franks LM (1954) Latent carcinoma of the prostate. J Pathol Bacteriol 68:603–616PubMedCrossRefGoogle Scholar
  12. 12.
    Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. JNCI 40:43–68PubMedGoogle Scholar
  13. 13.
    Harbitz TB, Haugen OA (1972) Histology of the prostate in elderly men. Acta Pathol Microbiol Immunol Scand [A] 80:756–768Google Scholar
  14. 14.
    Helpap B (1980) The biological significance of atypical hyperplasia of the prostate. Virchows Arch [A] 387:307–317CrossRefGoogle Scholar
  15. 15.
    Helpap B (1989) Do precursor lesions of prostatic carcinoma exist? World J Urol 7:27–33CrossRefGoogle Scholar
  16. 16.
    Huggins C, Johnson MA (1947) Carcinoma of the bladder and prostate. J Am Med Assoc 135:1146–1152PubMedGoogle Scholar
  17. 17.
    Isaacs JT (1984) The aging ACI/Seg versus Copenhagen male rats as a model for the study of prostatic carcinogenesis. Cancer Res 44:5785–5796PubMedGoogle Scholar
  18. 18.
    Kastendieck H (1980) Correlation between atypical primary hyperplasia and carcinoma of the prostate. Histologic studies on 180 total prostatectomies due to manifest carcinoma. Pathol Res Pract 169:366–387PubMedCrossRefGoogle Scholar
  19. 19.
    McNeal JE (1965) Morphogenesis of prostatic carcinoma. Cancer 18:1659–1666PubMedCrossRefGoogle Scholar
  20. 20.
    McNeal JE (1969) Origin and development of carcinoma in the prostate. Cancer 23:24–34PubMedCrossRefGoogle Scholar
  21. 21.
    Moore RA (1935) The morphology of small prostatic carcinoma. J Urol 33:224–234Google Scholar
  22. 22.
    Muir CS, Malhotra A (1987) Changing patterns of cancer incidence in five continents. Gann Monogr 33:3–23Google Scholar
  23. 23.
    Ohno Y, Aoki K, Kuroishi T (1984) Epidemiology of cancer of the urogenital organs in Japan. Rinsho Hinyokika 38:555–569Google Scholar
  24. 24.
    Parkin DM, Läära E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–197PubMedCrossRefGoogle Scholar
  25. 25.
    Rich AP (1935) On the frequency of occurrence of occult carcinoma of the prostate. J Urol 33:215–223Google Scholar
  26. 26.
    Rotkin ID (1979) Epidemiologic factors associated with prostatic cancer. In: Coffey DS, Isaacs JT (eds) Prostate cancer. Report no 9. UICC Technical Report Series 48:56–80Google Scholar
  27. 27.
    Sheldon CA, Williams RD, Trawley EE (1980) Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 124:626–631PubMedGoogle Scholar
  28. 28.
    Yamabe H, ten Kate FJW, Gallee MPW, Schroeder FH, Oishi K, Okada K, Yoshida O (1986) Stage A prostatic cancer: a comparative study in Japan and the Netherlands. World J Urol 4:136–140CrossRefGoogle Scholar
  29. 29.
    Yatani R, Shiraishi T, Nakakuki K, Kusano I, Takanari H, Hayashi T, Stemmermann GN (1988) Trends in frequency of latent prostate carcinoma in Japan from 1965–1979 to 1982–1986. JNCI 80:683–687PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • H. Schulze
    • 1
  1. 1.Urologische KlinikMarienhospitalHerne 1Germany

Personalised recommendations